Literature DB >> 13129594

Risk factors and prognosis of epilepsy in children with cerebral palsy in north-eastern Poland.

Wojciech Kułak1, Wojciech Sobaniec.   

Abstract

Though epilepsy occurs in 15-90% of children with cerebral palsy (CP) its clinical course is not well defined. We therefore conducted studies of 198 children with CP seen in Pediatric Neurology Department of the Medical Academy in Białystok between 1994 and, 2001. The aim was to evaluate the risk factors, incidence and prognosis of epilepsy in CP. The overall epilepsy incidence was 41.4%. Epilepsy most commonly affected children with spastic tetraplegia 65.6%. Low birth weight, neonatal seizures, seizures during the first year of life, family history of epilepsy, severity of CP and computer tomography findings were found to be related to significantly increased risk of epilepsy in children with CP in the logistic regression analysis. Intractable epilepsy occurred in 51.2%, while in spastic tetraplegia it was even higher (60%). Controlled epilepsy was observed in 83.3% of spastic diplegia and in 72.7% of spastic hemiplegia. Polytherapy was commonly used in children with spastic tetraplegia 59.5%. Partial seizures secondarily generalized, infantile spasms and Lennox-Gastaut syndrome were the most frequently observed seizures in epileptic children with CP. Epilepsy is common in children with CP and has poor prognosis.

Entities:  

Mesh:

Year:  2003        PMID: 13129594     DOI: 10.1016/s0387-7604(03)00040-8

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  11 in total

1.  Risk factors associated with epilepsy development in children with cerebral palsy.

Authors:  Elif Karatoprak; Gülhan Sözen; Sema Saltık
Journal:  Childs Nerv Syst       Date:  2019-04-22       Impact factor: 1.475

2.  Continuous electroencephalographic monitoring with radio-telemetry in a rat model of perinatal hypoxia-ischemia reveals progressive post-stroke epilepsy.

Authors:  Shilpa D Kadam; Andrew M White; Kevin J Staley; F Edward Dudek
Journal:  J Neurosci       Date:  2010-01-06       Impact factor: 6.167

3.  Epileptic and cognitive changes in children with cerebral palsy: an Egyptian study.

Authors:  Hamdy N El-Tallawy; Wafaa Ma Farghaly; Ghaydaa A Shehata; Reda Badry; Tarek A Rageh
Journal:  Neuropsychiatr Dis Treat       Date:  2014-05-29       Impact factor: 2.570

4.  Cerebral Palsy in 1-12 Year Old Children in Southern Iran.

Authors:  Soroor Inaloo; Pegah Katibeh; Masroor Ghasemof
Journal:  Iran J Child Neurol       Date:  2016

5.  Evaluation of Risk Factors for Epilepsy in Pediatric Patients with Cerebral Palsy.

Authors:  Małgorzata Sadowska; Beata Sarecka-Hujar; Ilona Kopyta
Journal:  Brain Sci       Date:  2020-07-25

Review 6.  Cerebral Palsy: Current Opinions on Definition, Epidemiology, Risk Factors, Classification and Treatment Options.

Authors:  Małgorzata Sadowska; Beata Sarecka-Hujar; Ilona Kopyta
Journal:  Neuropsychiatr Dis Treat       Date:  2020-06-12       Impact factor: 2.570

7.  Risk Factors of Intractable Epilepsy in Children with Cerebral Palsy.

Authors:  Yehia Hamed Abdel Maksoud; Hany Abdelaziz Suliman; Sameh ElSAYED Abdulsamea; Naglaa Mohamed Kamal; Ashraf Hamed Al-Shokray; Asmaa Obada Ibrahim; Hatem Hamed Elshorbagy; Mohamed Gamal El Din Fathallah; Ahmed Mahmoud Attia; Akram Elshafey Elsadek
Journal:  Iran J Child Neurol       Date:  2021

8.  Retrospective review of the epidemiology of epilepsy in special schools for children with cerebral palsy, learning difficulties, and language and communication difficulties.

Authors:  Danielle Samar Peet
Journal:  Mcgill J Med       Date:  2006-01

9.  The neuroimaging magnitude of pediatric brain atrophy in northern Tanzania.

Authors:  Richard Erasto Sungura; John Martin Spitsbergen; Emmanuel Abraham Mpolya; Elingarami Sauli; John-Mary Vianney
Journal:  Pan Afr Med J       Date:  2020-05-21

10.  The relationship between breast milk intake and speech in children with cerebral palsy

Authors:  Gül Demet Kaya Özçora
Journal:  Turk J Med Sci       Date:  2021-08-30       Impact factor: 0.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.